Kawasaki Disease: Clinical Findings Diagnostic Criteria - Fever and 4/5 of the following:
Kawasaki Disease - Timeline of Clinical Features and Complications - Fever >5
KAWASAKI DISEASE: CEREBROVASCULAR AND NEUROLOGIC COMPLICATIONS (Chapter 13) - Uncommon Causes of Stroke
A combination therapy for Kawasaki disease with severe complications: a case report in: Open Medicine Volume 15 Issue 1 (2019)
Unlikely association between Kawasaki disease and intracranial aneurysms: a prospective cohort study in: Journal of Neurosurgery: Pediatrics Volume 23 Issue 5 (2019)
PDF) Kawasaki disease with predominant central nervous system involvement
Kawasaki disease - Wikipedia
Neurological complications with COVID-19: A contemporaneous review Maramattom BV, Bhattacharjee S - Ann Indian Acad Neurol
PDF) Grisel syndrome as a complication of Kawasaki disease: A case report and review of the literature
Cardiovascular complications in 10 patients with Kawasaki disease | Download Table
CLINICAL-EPIDEMIOLOGICAL RELATION BETWEEN SARS-COV-2 AND KAWASAKI DISEASE: AN INTEGRATIVE LITERATURE
An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study - The Lancet
Atypical Kawasaki Disease in 2-Months Old Infant Presenting with Aseptic Meningitis | Semantic Scholar
Kawasaki Disease: Pathogenesis and Complications | Calgary Guide
Neurological involvement associated with COVID-19 infection in children
PDF) Meningoencephalitis as a Presentation of Kawasaki Disease
FEVER AND RASH IN A 5 MONTH OLD INFANT - ppt video online download
Similarities of the Clinical Manifestations of Kawasaki Disease and... | Download Table
Facial nerve palsy and Kawasaki disease
Kawasaki disease: AHA statement and recommendations | Contemporary Pediatrics
Medicina | Free Full-Text | Clinical Manifestations of Kawasaki Disease at Different Age Spectrum: A Ten-Year Study | HTML
Macrophage activation syndrome in children with Kawasaki disease: diagnostic and therapeutic approaches | SpringerLink
Internet Scientific Publications
Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a
